Clinical-radiomics nomogram for identifying HER2 status in patients with breast cancer: A multicenter study

PURPOSE: To develop and validate a clinical-radiomics nomogram based on radiomics features and clinical risk factors for identification of human epidermal growth factor receptor 2 (HER2) status in patients with breast cancer (BC). METHODS: Two hundred and thirty-five female patients with BC were enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Caiyun, Zhang, Juntao, Li, Jizhen, Shang, Hui, Li, Kejian, Jiao, Tianyu, Yin, Di, Li, Fuyan, Cui, Yi, Zeng, Qingshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490879/
https://www.ncbi.nlm.nih.gov/pubmed/36158700
http://dx.doi.org/10.3389/fonc.2022.922185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490879/
https://www.ncbi.nlm.nih.gov/pubmed/36158700
http://dx.doi.org/10.3389/fonc.2022.922185

Ejemplares similares